Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 14, 2020; 26(22): 3024-3033
Published online Jun 14, 2020. doi: 10.3748/wjg.v26.i22.3024
Published online Jun 14, 2020. doi: 10.3748/wjg.v26.i22.3024
Table 2 Evaluation of the detection value of COL10A1 in the diagnosis of gastric cancer patients.
AUC | P value | Cut-off values (ng/mL) | Sensitivity | Specificity | |
GC vs CFC | 0.9171 (0.8443 to 0.9899) | 0.0002 | 113.3 | 87.76% (75.76%-94.27%) | 100% (67.56%-100.0%) |
Early stage GC vs CFC | 0.8789 (0.7385 to 1.000) | 0.003 | 118.1 | 81.25% (56.99%-93.41%) | 100% (67.56%-100.0%) |
Advanced stage GC vs CFC | 1.000 (1.000 to 1.000) | 0.0001 | 113.3 | 100% (78.47%-100.0%) | 100% (67.56%-100.0%) |
Early stage vs Advanced stage | 0.7768 (0.5977 to 0.9558) | 0.0100 | 225.3 | 78.57% (52.41%-92.43%) | 81.25% (56.99%-93.41%) |
- Citation: Necula L, Matei L, Dragu D, Pitica I, Neagu AI, Bleotu C, Dima S, Popescu I, Diaconu CC, Chivu-Economescu M. High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients. World J Gastroenterol 2020; 26(22): 3024-3033
- URL: https://www.wjgnet.com/1007-9327/full/v26/i22/3024.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i22.3024